SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), reports that its associate company, SG Austria, presented data about its proprietary encapsulation of living cell technology, in particular for the treatment of pancreatic cancer, at the Cell Line Development and Engineering Asia Event. The meeting, held in Shanghai, February 21st – 23rd and organized by IBC Asia, is a new platform for the latest advances in the use of cells for production of therapeutics.
